Life Technologies has introduced two bioinformatics offerings, which will allow cancer researchers new avenues of access to one of the largest genomics databases available, compiled by the former Compendia Bioscience.
Oncomine Gene Browser will allow cancer researchers to search premier cancer genomics database for expression, copy number and mutation data while Ion Reporter Oncomine Workflow is an end-to-end bioinformatics solution to identify driver mutations for cancer research.
Life Technologies medical bioinformatics head Dan Rhodes said that Oncomine Gene Browser will enable the smaller pharma scientists to be competitive in research and drug development.
Oncomine Gene Browser is cost-effective option for academic, biotech and smaller pharma researchers whereas the Ion Reporter Oncomine Workflow will be available at no charge for an introductory period, making this bioinformatics accessible to any scientist.
Life Technologies Medical Sciences president Ronnie Andrews said that Oncomine Gene Browser constitutes a unique solution for scientists working in the drug discovery and companion diagnostics space.
The Oncomine platform is a product of Compendia Bioscience, a cancer bioinformatics company, which was acquired by Life Technologies in October 2012.
